anti-neoplastic urinary protein (ARP/TranXenoGen)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-neoplastic urinary protein (ARP/TranXenoGen)
Drug Alias NameANUP (TranXenoGen/Antitumor Research Products)ANUP
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAntitumor Research Products Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranXenoGen IncAntitumor Research Products Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A